In collaboration with Dr. Steven Weinman, M.D., Ph.D. (Director of the Liver Center at University of Kansas, Kansas City, Kansas), Cardax evaluated the capacity for a proprietary astaxanthin (ASTX) prodrug...

By Timothy J. King, Ph.D., Vice President, Research, and A. David Hieber, Ph.D., Associate Director, Biology Type 2 Diabetes Mellitus (T2DM) T2DM is one of the most common age related...

By Timothy J. King, Ph.D., Vice President, Research Osteoarthritis Background Osteoarthritis (OA) is the most common form of arthritis, a chronic disease of aging.  Effective and safe long-term treatment for...

By Timothy J. King, Ph.D., Vice President, Research The role of oxidative stress and inflammation in liver injury and liver dysfunction as well as the potential for antioxidants to ameliorate...

By Timothy J. King, Ph.D., Vice President, Research The role of oxidative stress and inflammation in liver injury and liver dysfunction as well as the potential for antioxidants to ameliorate liver disease has been established in both animal models and human trials [Sanchez-Valle et al. 2012; Pacana and Sanyal 2012]. Studies utilizing rodent models of liver disease have also demonstrated the efficacy of astaxanthin (ASTX) in ameliorating liver injury [Kang et al. 2001; Curek et…